Clinical trials
Psychotic Disorders trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Alfred | 7 |
| Bayside Health | 4 |
| Melbourne Health | 4 |
| Eli Lilly and Company | 2 |
| Swinburne University of Technology | 2 |
| The University of New South Wales | 2 |
| AstraZeneca | 1 |
| Brigham and Women's Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Menzies School of Health Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 27 |
| Schizophrenia | 17 |
| Mental Disorders | 5 |
| Bipolar Disorder | 4 |
| Mania | 2 |
| Mood Disorders | 2 |
| Affective Disorders, Psychotic | 1 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
| Attention Deficit and Disruptive Behavior Disorders | 1 |
Trials
Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.